Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-17T03:48:04.514Z Has data issue: false hasContentIssue false

The long-term effectiveness of coronavirus disease 2019 (COVID-19) vaccines: A systematic literature review and meta-analysis

Published online by Cambridge University Press:  14 February 2022

Alexandre R. Marra*
Affiliation:
Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, United StatesInstituto Israelita de Ensino e Pesquisa Albert Einstein, Hospital Israelita Albert Einstein, São Paulo, BrazilCenter for Access & Delivery Research & Evaluation (CADRE), Iowa City Veterans’ Affairs Health Care System, Iowa City, Iowa, United States
Takaaki Kobayashi
Affiliation:
Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States
Hiroyuki Suzuki
Affiliation:
Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, United StatesCenter for Access & Delivery Research & Evaluation (CADRE), Iowa City Veterans’ Affairs Health Care System, Iowa City, Iowa, United States
Mohammed Alsuhaibani
Affiliation:
Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, United StatesDepartment of Pediatrics, College of Medicine, Qassim University, Qassim, Saudi Arabia
Marin L. Schweizer
Affiliation:
Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, United StatesCenter for Access & Delivery Research & Evaluation (CADRE), Iowa City Veterans’ Affairs Health Care System, Iowa City, Iowa, United States
Daniel J. Diekema
Affiliation:
Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States
Bruna Marques Tofaneto
Affiliation:
Albert Einstein Medical College, São Paulo, Brazil
Luigi Makowski Bariani
Affiliation:
Albert Einstein Medical College, São Paulo, Brazil
Mariana de Amorim Auler
Affiliation:
Albert Einstein Medical College, São Paulo, Brazil
Jorge L. Salinas
Affiliation:
Stanford University, Stanford, California, United States
Michael B. Edmond
Affiliation:
West Virginia University School of Medicine, Morgantown, West Virginia, United States
João Renato Rebello Pinho
Affiliation:
Research and Development Sector, Clinical Laboratory, Hospital Israelita Albert Einstein, São Paulo, Brazil
Luiz Vicente Rizzo
Affiliation:
Instituto Israelita de Ensino e Pesquisa Albert Einstein, Hospital Israelita Albert Einstein, São Paulo, Brazil
*
Author for correspondence: Alexandre R. Marra, MD, University of Iowa Hospitals and Clinics, C51 GH, 200 Hawkins Drive, Iowa City, IA 52242. E-mail: alexandre-rodriguesmarra@uiowa.edu

Abstract

Background:

Although multiple studies revealed high vaccine effectiveness of coronavirus disease 2019 (COVID-19) vaccines within 3 months after the completion of vaccines, long-term vaccine effectiveness has not been well established, especially after the δ (delta) variant became prominent. We performed a systematic literature review and meta-analysis of long-term vaccine effectiveness.

Methods:

We searched PubMed, CINAHL, EMBASE, Cochrane Central Register of Controlled Trials, Scopus, and Web of Science from December 2019 to November 15, 2021, for studies evaluating the long-term vaccine effectiveness against laboratory-confirmed COVID-19 or COVID-19 hospitalization among individuals who received 2 doses of Pfizer/BioNTech, Moderna, or AstraZeneca vaccines, or 1 dose of the Janssen vaccine. Long-term was defined as >5 months after the last dose. We calculated the pooled diagnostic odds ratio (DOR) with 95% confidence interval for COVID-19 between vaccinated and unvaccinated individuals. Vaccine effectiveness was estimated as 100% × (1 − DOR).

Results:

In total, 16 studies including 17,939,172 individuals evaluated long-term vaccine effectiveness and were included in the meta-analysis. The pooled DOR for COVID-19 was 0.158 (95% CI: 0.157-0.160) with an estimated vaccine effectiveness of 84.2% (95% CI, 84.0- 84.3%). Estimated vaccine effectiveness against COVID-19 hospitalization was 88.7% (95% CI, 55.8%–97.1%). Vaccine effectiveness against COVID-19 during the δ variant period was 61.2% (95% CI, 59.0%–63.3%).

Conclusions:

COVID-19 vaccines are effective in preventing COVID-19 and COVID-19 hospitalization across a long-term period for the circulating variants during the study period. More observational studies are needed to evaluate the vaccine effectiveness of third dose of a COVID-19 vaccine, the vaccine effectiveness of mixing COVID-19 vaccines, COVID-19 breakthrough infection, and vaccine effectiveness against newly emerging variants.

Information

Type
Review
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Fig. 1.Literature search for articles on the long-term COVID-19 vaccine effectiveness among general population.

Figure 1

Table 1.Summary of Characteristics of Studies Included in the Systematic Literature Review

Figure 2

Table 2.Subset Analyses Evaluating Long-Term COVID-19 Vaccine Effectiveness Among Fully Vaccinated Individuals

Supplementary material: File

Marra et al. supplementary material

Marra et al. supplementary material

Download Marra et al. supplementary material(File)
File 261.5 KB